Picture of Ginkgo Bioworks Holdings logo

DNA — Ginkgo Bioworks Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Ginkgo Bioworks rises as Bayer extends agri-biotech partnership

** Shares of biotech co Ginkgo Bioworks DNA.N rise 3.3% to $12.41 premarket

** Co says Bayer extended multi-year partnership with Ginkgo to develop new biological products for farming

** DNA says the tie-up, which began in 2017, focuses on developing microbial solutions that help crops absorb nitrogen, reducing reliance on synthetic fertilizers

** Bayer will retain the rights to commercialize any products that result from the partnership, co says

** DNA based in Boston, develops tools to make it easier to engineer biological solutions for industries ranging from agriculture to healthcare

** Up to last close, stock was up ~22% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))

Recent news on Ginkgo Bioworks Holdings

See all news